For pharmaceutical manufacturers engaged in the synthesis of Dabigatran etexilate, securing a reliable supply of high-quality intermediates is paramount. Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate, identified by CAS number 212322-56-0, stands as a critical building block in this process. Understanding the key characteristics and sourcing strategies for this compound can significantly impact the efficiency and success of your production.

When seeking a manufacturer for this vital pharmaceutical intermediate, several factors should be at the forefront of your evaluation. Firstly, purity is non-negotiable. Look for specifications that clearly outline the minimum purity level, typically ≥98.0% for compounds like CAS 212322-56-0. Equally important are the impurity profiles; stringent limits on single and total impurities, such as ≤0.5% and ≤1.0% respectively, are indicative of a high-quality product. Reliable suppliers will readily provide Certificates of Analysis (CoA) detailing these critical parameters.

Beyond chemical purity, consider the physical form and stability. Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate is commonly supplied as a white to pale yellow crystalline solid, which suggests good handling and storage properties. Manufacturers should also provide clear guidance on storage conditions, often recommending cool, ventilated environments to maintain product integrity. The presence of detailed MSDS (Material Safety Data Sheet) information is also a strong indicator of a reputable supplier.

For procurement, engaging directly with manufacturers or their authorized distributors is often the most cost-effective approach. When you buy Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate, inquire about pricing structures for bulk purchases. Understanding the supply chain capabilities of potential suppliers, especially those based in regions like China known for chemical manufacturing, can provide a competitive advantage. A consistent and stable supply chain is crucial for uninterrupted API production.

In conclusion, when sourcing this essential Dabigatran etexilate intermediate, prioritize purity, adherence to specifications, and a reliable manufacturing partner. By carefully evaluating potential suppliers and their product offerings, pharmaceutical companies can ensure the quality and consistency required for successful drug synthesis. We encourage you to contact us for your procurement needs and experience the assurance of a trusted manufacturer.